Developments in rare bone diseases and mineral disorders.
- Published in:
- Therapeutic Advances in Chronic Disease, 2018, v. 9, n. 1, p. 51, doi. 10.1177/2040622317739538
- By:
- Publication type:
- Article
Works matching IS 20406223 AND DT 2018 AND VI 9 AND IP 1
Results: 4
1
2
Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.
- Published in:
- Therapeutic Advances in Chronic Disease, 2018, v. 9, n. 1, p. 5, doi. 10.1177/2040622317738910
- By:
- Publication type:
- Article
3
Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential.
- Published in:
- Therapeutic Advances in Chronic Disease, 2018, v. 9, n. 1, p. 33, doi. 10.1177/2040622317735283
- By:
- Publication type:
- Article
4
Management of functional dyspepsia: state of the art and emerging therapies.
- Published in:
- Therapeutic Advances in Chronic Disease, 2018, v. 9, n. 1, p. 23, doi. 10.1177/2040622317725479
- By:
- Publication type:
- Article